Related Experiment Video
Updated: Jun 4, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Summary
Drug therapy for newborns requires careful monitoring due to developmental factors affecting drug processing. Understanding pharmacokinetics is key to assessing infant responses and ensuring effective treatment.
Area of Science:
- Neonatal Pharmacology
- Pediatric Drug Therapy
- Clinical Pharmacokinetics
Background:
- Drug therapy aims for specific clinical outcomes.
- Newborns, both preterm and term, are a vulnerable population.
- Developmental immaturity impacts drug pharmacokinetics in neonates.
Purpose of the Study:
- To highlight the complexities of drug therapy in newborns.
- To emphasize the importance of monitoring clinical response.
- To guide healthcare providers in assessing drug efficacy in infants.
Main Methods:
- Review of pharmacologic principles.
- Focus on pharmacokinetic considerations in neonatal drug administration.
- Guidance for clinical assessment of patient response.
Main Results:
- Drug pharmacokinetics are significantly altered in newborns.
- Clinical monitoring is essential to evaluate drug effectiveness.
- Awareness of expected responses aids in therapy management.
Conclusions:
- Effective drug therapy in neonates necessitates understanding pharmacokinetic variations.
- Continuous clinical assessment is crucial for optimizing treatment outcomes.
- Pharmacologic principles guide safe and effective neonatal drug administration.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:19Nonlinear Pharmacokinetics: Overview
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...